A critical synthesis of these findings reveals that the protective effect of FMN against ALI is multifaceted, as it targets both oxidative stress (via Nrf2/HO-1) and inflammation (via NF-κB and PI3K/Akt) almost concurrently. The gene discussed is HMOX1; the disease is acute respiratory distress syndrome.